Currently Accepting Applications

Deadline: Sep. 1, 2017

Value & Term

Operating grants of up to $1.5 million each over four years are available from CIHR through the Strategy for Patient-Oriented Research (SPOR) to build capacity in innovative clinical trials:

CIHR SPOR Innovative Clinical Trial (iCT) Multi-Year Grant

Alberta Innovates will consider providing matching funds to Alberta-based applicants that are successful in this CIHR competition.

Objective:

The objectives of the CIHR SPOR Innovative Clinical Trial (iCT) Multi-Year Grant are to enable new and established investigators to undertake innovative clinical trials using new or existing methods, to support the development and testing of innovative methods, and to build capacity for iCT research through training and mentoring. This competition is to support innovative clinical trials using designs that are alternative to traditional Randomized Controlled Trials with application in areas ranging from product development to health system improvement. Using iCT methods can reduce the cost of conducting trials, the amount of time needed to answer research questions, and increase the relevance of research findings to patients, health care providers and/or policy makers. Adopting these alternative designs can also maximize the use of existing knowledge and data.

CIHR will provide approximately six successful grants up to $1.5 million each over four years that must be matched at a minimum of 1:1, by non-federal sources.

Requests for Alberta Innovates Support

Alberta Innovates will consider contributing towards the matching component for applications either:

1) led by an Alberta-based Nominated Principal Applicant (NPA); or

2) towards applications involving Alberta-based Principal Applicants (co-applicants) where the requested funds will be used in Alberta.

Phase 1 – Request for Matching Funds

Applicants seeking support should notify Alberta Innovates of their intention to apply by September 1, 2017.

The submission should include:

  • the names and contact details of the Nominated Principal Applicant (NPA) and the required additional Principal Applicants and/or Principal Knowledge Users;
  • how much matching funds are being requested from Alberta Innovates and what other sources of funding are anticipated; and,
  • a brief overview of the project and specifically how Alberta Innovates funds will be used.

Request for matching fund contributions are to be emailed to grants.health@albertainnvoates.ca

Phase 2  CIHR Full Application Submission

Successful Phase 1 applicants seeking Alberta Innovates funds will need to supply the following by January 5, 2017.

  • Approval from CIHR to submit a full application;
  • A detailed letter of request which includes:
    • the names and contact details of the Nominated Principal Applicant (NPA) and the required additional Principal Applicants and/or Principal Knowledge Users;
    • how much matching funds are being requested from AI; and,
    • a brief description of how Alberta Innovates funds will be used.
  • A one page research summary indicating how the size and scope of the proposed research can contribute to iCT capacity and improve personal health, the health of populations and/or the health delivery system in Alberta;
  • A budget that clearly identifies how the funds will be used to support Alberta-based research;
  • An updated list of additional matched funding sought/confirmed;
  • A copy of the draft proposal to be submitted to CIHR; and,
  • A CIHR Partnership Details Form.

Requests for Alberta Innovates funds will be assessed upon receipt of the required information as outlined above. Decisions for Alberta Innovates matching contribution will be made based upon alignment to Alberta Innovates’ mandate, potential impact to Albertans and the availability of funds. Priority will be given to Alberta-NPA led applications. We will email successful applicants an official letter of support and executed CIHR Partnership Details Form between January 8 and January 12, 2018.

Requests should be submitted to grants.health@albertainnvoates.ca

Eligible Expenses

Applicants receiving funds will be subject to the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC, SSHRC) Financial Administration Guide. Please refer to the CIHR website for more information on allowable costs. AI funds are not eligible for any indirect costs.

 AbSPORU Supports

Applicants should know that the Alberta SPOR SUPPORT Unit (AbSPORU) provides a virtual network of services, expertise and resources to support the increase and quantity of patient-oriented research in Alberta. To learn more and apply for services visit absporu.ca.

 

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Share on LinkedIn

For more information:
Bindi Ferguson, Senior Manager, Industry & Technology
Bindi.Ferguson@albertainnovates.ca
(780) 306-1099

Mike Christen, Officer, Grants Processing
Mike.Christen@albertainnovates.ca
(780) 809-2557